Keith Marchiando - 29 Aug 2022 Form 4 Insider Report for Zivo Bioscience, Inc. (ZIVO)

Role
Director, 10%+ Owner
Signature
/s/ Keith Marchiando
Issuer symbol
ZIVO
Transactions as of
29 Aug 2022
Net transactions value
$0
Form type
4
Filing time
31 Aug 2022, 16:12:16 UTC
Previous filing
25 Oct 2021
Next filing
06 Jun 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZIVO Nonstatutory Stock Option to Purchase Common Stock Award $0 +62,000 $0.000000 62,000 29 Aug 2022 Common Stock 62,000 $3.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was issued pursuant to the 2021 Equity Incentive Plan and vests as follows: 25% upon acceptance of the grant, and 25% on each of the next three calendar anniversaries of the grant.